Diogo Feleciano 11/13/25 Diogo Feleciano 11/13/25 Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study Read More Diogo Feleciano 10/10/24 Diogo Feleciano 10/10/24 Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases Read More
Diogo Feleciano 11/13/25 Diogo Feleciano 11/13/25 Booster Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Advance New Class of Proteasome Activator Medicines Towards First-in-Human Phase 1 Study Read More
Diogo Feleciano 10/10/24 Diogo Feleciano 10/10/24 Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases Read More
